HEXIM2-AS2 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC) tissues, HSAL3 is upregulated and activated by the TF HSF1 through its SE, which, in turn, interferes with the negative regulation of NOTCH signalling [44].